nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2A6—Fluorouracil—colon cancer	0.269	0.314	CbGbCtD
Isoniazid—CYP2C9—Capecitabine—colon cancer	0.156	0.182	CbGbCtD
Isoniazid—CYP2C8—Fluorouracil—colon cancer	0.133	0.155	CbGbCtD
Isoniazid—CYP1A2—Fluorouracil—colon cancer	0.103	0.12	CbGbCtD
Isoniazid—CYP2C9—Fluorouracil—colon cancer	0.0924	0.108	CbGbCtD
Isoniazid—CYP3A4—Irinotecan—colon cancer	0.056	0.0653	CbGbCtD
Isoniazid—CYP3A4—Vincristine—colon cancer	0.049	0.0571	CbGbCtD
Isoniazid—Neurotoxicity—Vincristine—colon cancer	0.00853	0.0597	CcSEcCtD
Isoniazid—Emotional distress—Fluorouracil—colon cancer	0.00725	0.0508	CcSEcCtD
Isoniazid—Neurotoxicity—Capecitabine—colon cancer	0.00556	0.0389	CcSEcCtD
Isoniazid—Diabetic—Methotrexate—colon cancer	0.00481	0.0337	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Methotrexate—colon cancer	0.00481	0.0337	CcSEcCtD
Isoniazid—Neuritis—Vincristine—colon cancer	0.00443	0.031	CcSEcCtD
Isoniazid—Neurotoxicity—Methotrexate—colon cancer	0.00414	0.029	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Irinotecan—colon cancer	0.00354	0.0248	CcSEcCtD
Isoniazid—Memory impairment—Capecitabine—colon cancer	0.00275	0.0192	CcSEcCtD
Isoniazid—Eruption—Methotrexate—colon cancer	0.00261	0.0183	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Capecitabine—colon cancer	0.00237	0.0166	CcSEcCtD
Isoniazid—Eosinophilia—Fluorouracil—colon cancer	0.00192	0.0134	CcSEcCtD
Isoniazid—Neuropathy peripheral—Vincristine—colon cancer	0.00181	0.0127	CcSEcCtD
Isoniazid—Diabetes mellitus—Capecitabine—colon cancer	0.0018	0.0126	CcSEcCtD
Isoniazid—Hepatic function abnormal—Capecitabine—colon cancer	0.00179	0.0125	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—colon cancer	0.00176	0.0124	CcSEcCtD
Isoniazid—Jaundice—Irinotecan—colon cancer	0.00176	0.0123	CcSEcCtD
Isoniazid—Neuropathy peripheral—Fluorouracil—colon cancer	0.00169	0.0118	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—colon cancer	0.00164	0.0115	CcSEcCtD
Isoniazid—Agranulocytosis—Fluorouracil—colon cancer	0.00161	0.0113	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—colon cancer	0.00151	0.0105	CcSEcCtD
Isoniazid—Gynaecomastia—Methotrexate—colon cancer	0.00144	0.0101	CcSEcCtD
Isoniazid—Lymphadenopathy—Methotrexate—colon cancer	0.00136	0.00956	CcSEcCtD
Isoniazid—Diabetes mellitus—Methotrexate—colon cancer	0.00134	0.00938	CcSEcCtD
Isoniazid—Ill-defined disorder—Irinotecan—colon cancer	0.00131	0.00915	CcSEcCtD
Isoniazid—Malaise—Irinotecan—colon cancer	0.00127	0.00889	CcSEcCtD
Isoniazid—Convulsion—Vincristine—colon cancer	0.00125	0.00877	CcSEcCtD
Isoniazid—Hyperglycaemia—Capecitabine—colon cancer	0.00122	0.00854	CcSEcCtD
Isoniazid—Discomfort—Irinotecan—colon cancer	0.00118	0.00829	CcSEcCtD
Isoniazid—Neuropathy peripheral—Capecitabine—colon cancer	0.00118	0.00828	CcSEcCtD
Isoniazid—Jaundice—Capecitabine—colon cancer	0.00118	0.00823	CcSEcCtD
Isoniazid—Convulsion—Fluorouracil—colon cancer	0.00117	0.00818	CcSEcCtD
Isoniazid—Thrombocytopenia—Vincristine—colon cancer	0.00115	0.00809	CcSEcCtD
Isoniazid—Discomfort—Fluorouracil—colon cancer	0.00113	0.00794	CcSEcCtD
Isoniazid—Agranulocytosis—Capecitabine—colon cancer	0.00113	0.00788	CcSEcCtD
Isoniazid—Thrombocytopenia—Irinotecan—colon cancer	0.00112	0.00788	CcSEcCtD
Isoniazid—Anorexia—Vincristine—colon cancer	0.00112	0.00787	CcSEcCtD
Isoniazid—Anorexia—Irinotecan—colon cancer	0.0011	0.00767	CcSEcCtD
Isoniazid—Hepatitis—Capecitabine—colon cancer	0.00108	0.00758	CcSEcCtD
Isoniazid—Thrombocytopenia—Fluorouracil—colon cancer	0.00108	0.00754	CcSEcCtD
Isoniazid—Paraesthesia—Vincristine—colon cancer	0.00106	0.00742	CcSEcCtD
Isoniazid—Anorexia—Fluorouracil—colon cancer	0.00105	0.00734	CcSEcCtD
Isoniazid—Paraesthesia—Irinotecan—colon cancer	0.00103	0.00722	CcSEcCtD
Isoniazid—Decreased appetite—Vincristine—colon cancer	0.00103	0.00718	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Vincristine—colon cancer	0.00102	0.00713	CcSEcCtD
Isoniazid—Fatigue—Vincristine—colon cancer	0.00102	0.00712	CcSEcCtD
Isoniazid—Dyspepsia—Irinotecan—colon cancer	0.00101	0.00708	CcSEcCtD
Isoniazid—Decreased appetite—Irinotecan—colon cancer	0.000999	0.00699	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—colon cancer	0.000997	0.00698	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Irinotecan—colon cancer	0.000992	0.00695	CcSEcCtD
Isoniazid—Fatigue—Irinotecan—colon cancer	0.00099	0.00694	CcSEcCtD
Isoniazid—Paraesthesia—Fluorouracil—colon cancer	0.000988	0.00692	CcSEcCtD
Isoniazid—Dyspepsia—Fluorouracil—colon cancer	0.000969	0.00678	CcSEcCtD
Isoniazid—Decreased appetite—Fluorouracil—colon cancer	0.000956	0.0067	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00095	0.00665	CcSEcCtD
Isoniazid—Feeling abnormal—Irinotecan—colon cancer	0.000947	0.00663	CcSEcCtD
Isoniazid—Body temperature increased—Vincristine—colon cancer	0.000933	0.00653	CcSEcCtD
Isoniazid—Body temperature increased—Irinotecan—colon cancer	0.000908	0.00636	CcSEcCtD
Isoniazid—Feeling abnormal—Fluorouracil—colon cancer	0.000907	0.00635	CcSEcCtD
Isoniazid—Ill-defined disorder—Capecitabine—colon cancer	0.000874	0.00612	CcSEcCtD
Isoniazid—Body temperature increased—Fluorouracil—colon cancer	0.00087	0.00609	CcSEcCtD
Isoniazid—Hypersensitivity—Vincristine—colon cancer	0.000869	0.00609	CcSEcCtD
Isoniazid—Malaise—Capecitabine—colon cancer	0.00085	0.00595	CcSEcCtD
Isoniazid—Hypersensitivity—Irinotecan—colon cancer	0.000846	0.00593	CcSEcCtD
Isoniazid—Asthenia—Vincristine—colon cancer	0.000846	0.00593	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—colon cancer	0.000837	0.00587	CcSEcCtD
Isoniazid—Asthenia—Irinotecan—colon cancer	0.000824	0.00577	CcSEcCtD
Isoniazid—Hypersensitivity—Fluorouracil—colon cancer	0.000811	0.00568	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—colon cancer	0.000806	0.00564	CcSEcCtD
Isoniazid—Discomfort—Capecitabine—colon cancer	0.000792	0.00555	CcSEcCtD
Isoniazid—Thrombocytopenia—Capecitabine—colon cancer	0.000753	0.00527	CcSEcCtD
Isoniazid—Vomiting—Vincristine—colon cancer	0.00075	0.00525	CcSEcCtD
Isoniazid—Rash—Vincristine—colon cancer	0.000744	0.00521	CcSEcCtD
Isoniazid—Anorexia—Capecitabine—colon cancer	0.000733	0.00513	CcSEcCtD
Isoniazid—Vomiting—Irinotecan—colon cancer	0.00073	0.00512	CcSEcCtD
Isoniazid—Rash—Irinotecan—colon cancer	0.000724	0.00507	CcSEcCtD
Isoniazid—Nausea—Vincristine—colon cancer	0.000701	0.00491	CcSEcCtD
Isoniazid—Vomiting—Fluorouracil—colon cancer	0.0007	0.0049	CcSEcCtD
Isoniazid—Rash—Fluorouracil—colon cancer	0.000694	0.00486	CcSEcCtD
Isoniazid—Paraesthesia—Capecitabine—colon cancer	0.00069	0.00484	CcSEcCtD
Isoniazid—Nausea—Irinotecan—colon cancer	0.000682	0.00478	CcSEcCtD
Isoniazid—Dyspepsia—Capecitabine—colon cancer	0.000677	0.00474	CcSEcCtD
Isoniazid—Decreased appetite—Capecitabine—colon cancer	0.000668	0.00468	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Capecitabine—colon cancer	0.000664	0.00465	CcSEcCtD
Isoniazid—Fatigue—Capecitabine—colon cancer	0.000663	0.00464	CcSEcCtD
Isoniazid—Nausea—Fluorouracil—colon cancer	0.000654	0.00458	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—colon cancer	0.000651	0.00456	CcSEcCtD
Isoniazid—Feeling abnormal—Capecitabine—colon cancer	0.000634	0.00444	CcSEcCtD
Isoniazid—Malaise—Methotrexate—colon cancer	0.000632	0.00443	CcSEcCtD
Isoniazid—Body temperature increased—Capecitabine—colon cancer	0.000608	0.00426	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—colon cancer	0.000608	0.00426	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—colon cancer	0.00059	0.00413	CcSEcCtD
Isoniazid—Hypersensitivity—Capecitabine—colon cancer	0.000566	0.00397	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—colon cancer	0.00056	0.00392	CcSEcCtD
Isoniazid—Asthenia—Capecitabine—colon cancer	0.000552	0.00386	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—colon cancer	0.000546	0.00382	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—colon cancer	0.000514	0.0036	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—colon cancer	0.000504	0.00353	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—colon cancer	0.000498	0.00348	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—colon cancer	0.000494	0.00346	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—colon cancer	0.000493	0.00346	CcSEcCtD
Isoniazid—Vomiting—Capecitabine—colon cancer	0.000489	0.00342	CcSEcCtD
Isoniazid—Rash—Capecitabine—colon cancer	0.000485	0.0034	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—colon cancer	0.000472	0.0033	CcSEcCtD
Isoniazid—Nausea—Capecitabine—colon cancer	0.000457	0.0032	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—colon cancer	0.000452	0.00317	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—colon cancer	0.000422	0.00295	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—colon cancer	0.000411	0.00288	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—colon cancer	0.000364	0.00255	CcSEcCtD
Isoniazid—Rash—Methotrexate—colon cancer	0.000361	0.00253	CcSEcCtD
Isoniazid—Nausea—Methotrexate—colon cancer	0.00034	0.00238	CcSEcCtD
